DT389-YP7, a Recombinant Immunotoxin against Glypican-3 That Inhibits Hepatocellular Cancer Cells: An In Vitro Study
Hepatocellular carcinoma (HCC) is one of the high-metastatic types of cancer, and metastasis occurs in one-third of patients with HCC. To maintain the effectiveness of drug compounds on cancer cells and minimize their side effects on normal cells, it is important to use new approaches for overcoming...
Saved in:
Main Authors: | Hamid Hashemi Yeganeh, Mohammad Heiat, Marek Kieliszek, Seyed Moayed Alavian, Ehsan Rezaie |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/2e5e1fe43e934ac890c9e94c1a657670 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IMMUNOHISTOCHEMICAL EXPRESSION OF GLYPICAN-3 IN HEPATOCELLULAR CARCINOMA
by: Dr Syed Salman Ali, et al.
Published: (2018) -
Antibody-Based Immunotoxins for Colorectal Cancer Therapy
by: Laura Sanz, et al.
Published: (2021) -
Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin
by: AVILA,ANA D, et al.
Published: (2007) -
Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential
by: Yu Y, et al.
Published: (2017) -
PRODUCTION OF RECOMBINANT PROTEIN CRM197 IN ESCHERICHIA COLI
by: I. V. Dukhovlinov, et al.
Published: (2015)